Dr. Majd Ibrahim, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 50 W Broadway Ste 300, Salt Lake Cty, UT 84101 Phone: 801-738-8938 |
News Archive
Women with the BRCA1 or BRCA2 gene mutations, which are linked to a very high risk of breast and ovarian cancer, can safely take hormone-replacement therapy (HRT) to mitigate menopausal symptoms after surgical removal of their ovaries, according to new research from the Perelman School of Medicine at the University of Pennsylvania which will be presented Monday, June 6 during the American Society for Clinical Oncology's annual meeting.
Quality of life for women treated with a more targeted radiotherapy treatment - called accelerated partial breast irradiation - is at least as good as quality of life for women treated with standard radiotherapy, according to research presented at the ESTRO 37 conference and published simultaneously in The Lancet Oncology.
Halozyme Therapeutics, Inc. announced today that it has entered into a worldwide Collaboration and License Agreement with Pfizer Inc. for the purpose of developing and commercializing products combining proprietary Pfizer biologics with Halozyme's Enhanze technology.
Children and young adults who receive CAR T-cell therapy for the most common childhood cancer - acute lymphoblastic leukemia - suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a new study finds.
Pregnant women produce extra progesterone, which puts them at greater risk for gallstones. When the stones become problematic, causing painful attacks, a surgeon may recommend that the diseased gallbladder be taken out by performing an operation known as a cholecystectomy.
› Verified 9 days ago